Insurance

JT&N has one of the most highly regarded insurance law practices in China. Our clients include the largest multinational insurance institutions in the world as well as leading Chinese insurers. Our insurance lawyers advise clients on the rapidly-evolving legal and regulatory framework governing the insurance industry in China, and have structured several first-in-the-market transactions in the insurance sector.

JT&N insurance lawyers are acknowledged experts in the area of insurance regulation with particular expertise in regulatory compliance, and we work closely with our clients on virtually every aspect of the requirements, design, implementation and monitoring of their in-China compliance systems.

We pride ourselves on our ability to successfully steer our clients through the legal and regulatory challenges that face the insurance industry in China today. To date, JT&N has been successful in obtaining every regulatory approval or business license the firm has sought on behalf of its clients. In addition, JT&N has satisfactorily resolved numerous complex disputes involving employees, business partners, in-country management and PRC administrative agencies on behalf of our insurance clients.

The firm’s insurance practice covers the full spectrum of matters, including mergers and acquisitions on behalf of insurance companies and in the insurance sector; the establishment of green-field insurance operations in China; the formation of insurance joint ventures; the structuring of distribution alliances with local business partners; and resolution of disputes between partners or customers. The firm has in-depth experience in every sector of the PRC insurance industry, including life and non-life, direct and reinsurance, and traditional as well as innovative underwriting and distribution. We regularly advise brokers, general agencies, and investors in the insurance field. Our experience in insurance industry has resulted, among other things, in JT&N being selected by several non-insurance multinational companies to act as their counsel on employee benefit plans in China, particularly in the area of supplementary pension plans.

JT&N insurance attorneys all have substantial expertise in the areas of PRC corporate law, M&A transactions and asset management. JT&N lawyers in other practice areas provide seamless multidisciplinary support to the firm’s insurance clients in banking, corporate compliance, real estate, dispute resolution, labor and employment, intellectual property and tax law.

Representative Deals

In the past 6 years, we have advised:
  • John Hancock Financial Services Inc. in obtaining its China license and negotiating its life insurance joint venture in China
  • Citi Insurance of Citigroup in selecting joint venture partners, assessing potential acquisdition targets, negotiating its life joint venture and obtaining life insurance license in China
  • A major U.S. property and casualty company in obtaining its China license, forming distribution alliances with local partners, selecting acquisition targets and on-going corporate compliance and legal matters in China
  • Samsung Life in forming its China strategy
  • Kyobo Life in forming its China strategy and establishing its representative office in China
  • A major U.S. health company in establishing its representative office in China
  • The direct marketing unit of a major European insurance conglomerate in establishing a new distribution channel in China
  • Mercer Consulting Co. in selecting acquisition targets and acquiring a stake in a local insurance broker
  • Lloyd’s of London and its wholly-owned reinsurance company on PRC regulatory and legal issues in its on-going China operations
  • Insurance operation of a major global financial conglomerate on establishing its insurance operation in China
  • A major US broker in applying for its China green-field license
  • A major German re-insurance group in establishing its branch and on-going operations in China
  • A major Asian financial group in its dispute resolution with the PRC insurance regulator
  • A German health company in forming its China strategy